|Articles|December 21, 2010

EORTC MODULE 2 v4

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Subscribe Now!

Related Content

Addressing Structural Challenges in Cancer Trial Participation

ByShanthi Sivendran, MD, MSCR, MBA,Andy Studna, Senior Editor

January 5th 2026

Clarifying Ownership of IRT Data in Clinical Trials: Distinguishing Investigator-Controlled Data from Sponsor Operational Data

ByMohammed Najmul Hasan, MPharm

January 2nd 2026

Measuring Barriers to Improve Enrollment and Retention

ByShanthi Sivendran, MD, MSCR, MBA,Andy Studna, Senior Editor

January 2nd 2026

ACT Brief: Support Services and Cancer Trial Access, 2025’s Most-Watched ACT Video Interviews, and FDA Approval of Narsoplimab

ByAndy Studna, Senior Editor

January 2nd 2026

© photon_photo - © photon_photo - stock.adobe.com

Our Top 5 Most Viewed Video Interviews in 2025

ByAndy Studna, Senior Editor

December 31st 2025

EORTC MODULE 2 v4

Newsletter

Related Content

Addressing Structural Challenges in Cancer Trial Participation

Clarifying Ownership of IRT Data in Clinical Trials: Distinguishing Investigator-Controlled Data from Sponsor Operational Data

Measuring Barriers to Improve Enrollment and Retention

ACT Brief: Support Services and Cancer Trial Access, 2025’s Most-Watched ACT Video Interviews, and FDA Approval of Narsoplimab

Our Top 5 Most Viewed Video Interviews in 2025

Trending on Applied Clinical Trials Online

Clarifying Ownership of IRT Data in Clinical Trials: Distinguishing Investigator-Controlled Data from Sponsor Operational Data

Measuring Barriers to Improve Enrollment and Retention

Addressing Structural Challenges in Cancer Trial Participation

ACT Brief: Support Services and Cancer Trial Access, 2025’s Most-Watched ACT Video Interviews, and FDA Approval of Narsoplimab